Dizi-Plus Tablet
Marketer
Shinto Organics (P) Limited
Salt Composition
Glucosamine (750mg) + Diacerein (50mg) + Methyl Sulfonyl Methane (250mg)
Overview Dizi-Plus Tablet
Tri-Med OA Relief tablets combine three active ingredients to manage osteoarthritis. This medication targets pain and swelling by suppressing inflammation, thereby easing joint friction and improving mobility. Tri-Med OA Relief may be used independently or as part of a broader treatment plan, always taken with food to minimize stomach upset. Adhere strictly to your doctor's prescribed dosage and duration; discontinue use only under their guidance. Common side effects include nausea, diarrhea, constipation, indigestion, heartburn, and altered urine color. Report any persistent or worsening side effects to your physician, who can advise on mitigating strategies. Individual suitability varies; consult your doctor regarding pre-existing conditions or other medications you're using, especially if you are pregnant or breastfeeding.
Uses of Dizi-Plus Tablet
Degenerative joint disease
Major Benefits of Dizi-Plus Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dizi-Plus Tablets should be administered with food.
Common Side effects of Dizi-Plus Tablet:
- Nausea
- Diarrhea
- Constipation
- Indigestion
- Heartburn
- Urine discoloration
How to use Dizi-Plus Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dizi-Plus Tablet whole; do not crush, chew, or break it. Administer this medication with a meal.
How Dizi-Plus Tablet works:
Osteoarthritis is addressed by Dizi-Plus Tablets, a formulation uniting glucosamine, diacerein, and methylsulfonylmethane (MSM). Glucosamine and diacerein boost proteoglycan production, while MSM, a dietary supplement, contributes to cartilage regeneration within the joints. This combined action promotes joint repair, with MSM further mitigating associated inflammation.
SAFETY ADVICE
AlcoholCAUTION
Use of Dizi-Plus Tablet with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on Dizi-Plus Tablet use in pregnancy is absent. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
No data exists on the effects of Dizi-Plus Tablet use while breastfeeding. Seek medical advice.
DrivingCONSULT YOUR DOCTOR
The effect of Dizi-Plus Tablet on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Use of Dizi-Plus Tablet in individuals with kidney impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
LiverUNSAFE
Patients with liver disorders should likely abstain from Dizi-Plus Tablets due to potential safety concerns. Medical advice is recommended.
What if you forget to take Dizi-Plus Tablet :
Should you forget a Dizi-Plus Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dizi-Plus Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
3,018 People bought this recently